Фармакокинетика и Фармакодинамика (Nov 2018)

Study of the pharmacokinetics of antituberculosis drug Biomairin

  • Sh. A. Shomurotov,
  • E. M. Sultanova,
  • M. K. Salakhutdinova,
  • U. J. Ishimov,
  • J. F. Ziyavitdinov,
  • O. N. Veshkurova,
  • A. S. Turaev

DOI
https://doi.org/10.24411/2587-7836-2018-10030
Journal volume & issue
Vol. 0, no. 4
pp. 50 – 55

Abstract

Read online

Resume. The results of a studying the pharmacokinetics of the anti-tuberculosis drug Biomayrin in experimental animals (rats) after oral administration were presented. A comparative analysis of the pharmacokinetic parameters of Biomayrin with a comparing drug (a mixture of rifampicin, ethambutol and isoniazid) showed that the bioavailability of isoniazid increased four times as a part of Biomayrin, the ethambutol and rifampicin three times compared to the comparing drug, thereby showing a prolonged effect. It should also be noted that the introduction of isoniazid into the polysaccharide matrix retards its metabolism to the therapeutically inactive acetylisoniazid.

Keywords